Dr. Neil Singla, Chief Executive Officer of Lotus Clinical Research will chair the 4th annual American Pain Society Conference on Analgesic Trials on Wednesday, April 3, 2019 in Milwaukee, Wisconsin.
PASADENA, CA – February 11, 2019
Registration is open for the American Pain Society’s 4th Annual APS-CAT conference on Wednesday, April 3 (day 1 of the APS Annual Meeting) in Milwaukee:
http://americanpainsociety.org/meetings-and-events/2019-scientific-meeting/conference-on-analgesic-trials
APS-CAT is a forum for experts from industry, academia and regulatory bodies to come together and discuss new ideas and best practices in the design and conduct of clinical pain trials. The theme of this year’s APS-CAT is Accelerating Development of Non-Opioid Pain Medicines.
In past years we’ve had up to 200 attendees gather to hear presentations from thought leaders in the field and participate in open Q & A.
This year’s speakers include:
As well as key drug development executives sharing insider perspectives on scientific, regulatory and economic concerns for rapid development of non-opioid analgesics:
Register today at http://americanpainsociety.org/meetings-and-events/2019-scientific-meeting/conference-on-analgesic-trials
Contact:
Hadley Rakowski
Lotus Clinical Research
802-343-5470
hrakowski@lotuscr.com
www.lotuscr.com